Prof. Tian Ye | Chemical Drugs | Best Researcher Award
National Institutes For Food and Drug Control | China
AUTHOR PROFILE
DR. TIAN YE: ACADEMIC AND PROFESSIONAL PROFILE
šEARLY ACADEMIC PURSUITSĀ
Dr. Tian Ye received his Bachelor of Science (B.S.) degree in 2008 and his Ph.D. degree in 2011 from Shenyang Pharmaceutical University and the Institute of Materia Medica, Chinese Academy of Medical Sciences, respectively. These formative years laid the foundation for his expertise in pharmaceutical sciences and quality control of chemical drugs.
š¢PROFESSIONAL ENDEAVORSĀ
In June 2012, Dr. Ye joined the National Institutes for Food and Drug Control. His work at this prestigious institution underscores his dedication to ensuring the safety and efficacy of chemical drugs. His role involves rigorous analysis and monitoring, ensuring that pharmaceutical products meet stringent quality standards.
š¬CONTRIBUTIONS AND RESEARCH FOCUS ON CHEMICAL DRUGS
Dr. Ye’s research primarily focuses on the quality control of chemical drugs and the identification and management of genotoxic impurities in these substances. His meticulous approach to ensuring drug safety has led to significant advancements in the field. He has authored over 30 scientific publications, contributing valuable knowledge and insights to the pharmaceutical community.
šIMPACT AND INFLUENCEĀ
Dr. Ye’s work has had a profound impact on the field of pharmaceutical sciences. His research on genotoxic impurities has paved the way for safer drug formulations, reducing potential risks to patients. His publications are widely cited, reflecting the importance and influence of his contributions.
šACADEMIC CITESĀ
With over 30 scientific publications to his name, Dr. Ye has made substantial contributions to academic literature. His work is frequently referenced by peers, highlighting his role as a thought leader in the field of pharmaceutical quality control.
šLEGACY AND FUTURE CONTRIBUTIONSĀ
Dr. Ye’s legacy is built on his unwavering commitment to improving drug safety. With over 10 licensed patents, his innovative approaches continue to shape the future of pharmaceutical sciences. His ongoing research and professional endeavors promise to further enhance drug quality control measures, ensuring better health outcomes for patients worldwide.
šIMPORTANT TOPICSĀ
- Quality Control of Chemical Drugs š: Dr. Ye’s primary area of expertise, focusing on ensuring the safety and efficacy of pharmaceutical products.
- Genotoxic Impurities š§¬: A critical aspect of Dr. Ye’s research, addressing the presence of harmful impurities in chemical drugs and developing methods to detect and manage them.
- Scientific Publications š: Dr. Ye’s extensive body of work, consisting of over 30 scientific articles, underscores his contributions to the field.
- Licensed Patents š : With over 10 patents to his name, Dr. Ye’s innovations have made a significant impact on pharmaceutical sciences and drug safety.
Dr. Tian Ye’s career is marked by his dedication to ensuring the highest standards of quality in pharmaceutical products, making significant contributions to both academic research and practical applications in drug safety. His work continues to influence the field, promising a future of safer and more effective medications.
šš¬Notable Publication:
TRACE LEVEL QUANTIFICATION OF 4-METHYL-1-NITROSOPIPERAZIN IN RIFAMPICIN CAPSULES BY LC-MS/MS
- Authors: Tao, X., Tian, Y., Liu, W.-H., Yao, S., Yin, L.
- Journal: Frontiers in Chemistry
- Year: 2022
DETERMINATION OF NITRITE ION IN RIFAMPICIN AND RIFAPENTINE CAPSULES BY SOLID PHASE EXTRACTION-ION CHROMATOGRAPHY
- Authors: Tian, Y., Feng, Y.-Y., Tao, X.-S., Chong, X.-M., Yin, L.-H.
- Journal: Chinese Journal of New Drugs
- Year: 2023
ESTABLISHMENT OF NATIONAL REFERENCE STANDARD OF IDARUBICIN HYDROCHLORIDE
- Authors: Tian, Y., Chong, X.-M., Liu, Y., Yao, S.-C.
- Journal: Chinese Journal of New Drugs
- Year: 2022
ANALYSIS OF RELATED SUBSTANCES AND STABILITY OF MOXIFLOXACIN HYDROCHLORIDE TABLETS
- Authors: Chong, X.-M., Tian, Y., Wang, L.-X., Liu, Y., Xu, M.-Z.
- Journal: Chinese Journal of New Drugs
- Year: 2022
DEVELOPMENT OF NATIONAL REFERENCE STANDARD OF 4-DEMETHYL-DAUNORUBICIN HYDROCHLORIDE
- Authors: Tao, X.-S., Tian, Y., Liu, W.-H., Yin, L.-H., Xu, M.-Z.
- Journal: Chinese Journal of New Drugs
- Year: 2022